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Abstract 
 
Objective(s) 
In this study, effects of chronic administration of oral natural honey against ischemia/reperfusion (I/R)-
induced cardiac arrhythmias were investigated in isolated rat heart.  
Materials and Methods 
Male Wistar rats were divided into four groups (n= 10-14 rats in each group) and fed with natural honey           
(1%, 2% and 4% dissolved in the drinking water) for 45 days except for the control group. After anesthesia, 
the rats’ hearts were isolated quickly, mounted on a Langendorff apparatus and perfused with a modified 
Krebs-Henseleit solution during stabilization, 30 min regional ischemia followed by 30 min reperfusion. The 
ECGs were recorded throughout the experiments to analyze cardiac arrhythmias based on the Lambeth 
conventions.  
Results 
In the ischemic phase, honey (1%) significantly reduced (P<0.05) the number and duration of ventricular 
tachycardia (VT). Honey (1% and 2%) also significantly decreased number of ventricular ectopic beats 
(VEBs). In addition, incidence and duration of reversible ventricular fibrillation (Rev VF) were lowered by 
honey 2% (P<0.05). During reperfusion time, VT incidence was 73% in the control group, however natural 
honey (1%) decreased it to 22% (P<0.05). Honey also produced significant reduction in the incidences of 
total VF, Rev VF, duration and number of VT.  
Conclusion 
For the first time, the results of present study demonstrated protective effects of chronic oral honey 
administration against I/R-induced arrhythmias in isolated rat heart. Antioxidant activity, the existence of 
energy sources such as glucose and fructose and improvement of some hemodynamic functions might be 
responsible for these effects. 
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Introduction 
Cardiac arrhythmias remain a major source of 
morbidity and mortality in developed countries 
(1). In cardiac surgery and myocardial infarction, 
ventricular arrhythmias such as ventricular 
tachycardia (VT) and ventricular fibrillation 
(VF) are the most important causes of mortality 
(2). Myocardial ischemia/reperfusion (I/R) 
results in significant damage to the heart. 
Ischemic condition results in the inhibition of 
fatty acid metabolism then accumulation of their 
toxic metabolites in the heart. These molecules 
have been shown to be deleterious to the 
recovery of myocardial function of the 
reperfused heart (3, 4) and have been shown as a 
cause of ventricular arrhythmias (5). 
Honey is a natural substance produced by 
honey bees from nectar or blossoms or from 
the secretion of living parts of plants or 
excretions of plants (6). It primarily contains 
sugar (95–99 % of honey dry matter) and 
water. Fructose (38.2 %) and glucose (31.3 %) 
are the most abundant content of sugars in 
honey composition (7).
  Small quantities of 
minerals such as potassium (the most 
abundant), calcium, copper, iron, manganese 
and phosphorus are present in honey. The 
main enzymes in natural honey are invertase, 
diastase and glucose oxidase. In addition, 
several vitamins such as vitamins C, B1 
(thiamine), riboflavin, nicotinic acid, 
panthothenic acid and B6 are also found (8). 
Although honey has been applied for 
medicinal purposes since ancient times (9), it 
has a limited use in modern medicine due to 
lack of scientific support (10). Inhibitory 
effects of natural honey have been reported on 
around 60 species of bacteria including 
aerobes and anaerobes, Gram-positives and 
Gram-negatives (11). Antifungal action has 
been observed for some yeasts and species of 
Aspergillus and Penicillium, as well as all the 
common dermatophytes (8). Honey has been 
used as wound barrier against tumor 
implantation in laparoscopic oncological 
surgery (12). It also has a potential therapeutic 
role in the treatment of gingivitis and 
periodontal disease (12). In addition, some 
findings indicated that honey has anti-
inflammatory effect and causes a reduction in 
necrosis tissues (13, 14). Antioxidant activity 
of natural honey was previously reported by 
many researchers (15-18). In a cultured 
endothelial cell line subjected to oxidative 
stress, a multifloral origin honey showed 
potent activity against free radicals, 
suppression/prevention of cell damage, 
inhibition of cell membrane oxidation, 
reduction of intracellular reactive oxygen 
spices (ROS), and production and recovery of 
intracellular reduced glutathione  (GSH). 
Flavonoids and phenolic acids were the main 
compounds of honey mediating the above-
mentioned protective effects (19). In natural 
wild honey, the total antioxidant capacity was 
found to be very pronounced as relatively high 
levels of reduced glutathione, vitamin C and 
superoxide dismutase activity (20). In the 
study of Gheldof et al, acute consumption of 
buckwheat honey significantly increased 
oxygen radical absorbance capacity in human 
serum (17). Schramm et al described the 
effects of oral buckwheat honey (1.5 g/kg) on 
the antioxidant and reducing capacities of 
plasma in healthy adults. Following 
consumption of the agent, plasma total-
phenolic content and antioxidant capacities 
increased. It seems that phenolic antioxidants 
may augment defenses against oxidative stress 
(21).  In  another  study,  10%  honey  feeding          
for 6 weeks in rats produced significant 
reduction in HbA1c, triglyceride levels and 
weight gain compared to sucrose and mixed 
sugars (22). Bahrami et al demonstrated that 
administration  of  oral  natural  honey  for                 
8 weeks in 48 diabetic type 2 patients had 
beneficial  effects  on  body  weight,               
total cholesterol, low-density lipoprotein-
cholesterol (LDL-C) and triglyceride reduction 
and increasing high-density lipoprotein-
cholesterol (HDL-C) (23). In addition, 
consumption of natural honey (70 g daily for 
30 days) ameliorated cardiovascular risk 
factors and reduced total cholesterol, LDL-C, 
triacylglycerole, C-reactive protein (CRP), 
fasting blood glucose (FBG), and increased 
HDL-C in overweight or obese individuals 
(24). In the study of Noori et al, single dose 
oral  honey  and  consumption  of  honey            
(15 days) in human subjects reduced  
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cholesterol, LDL-C, and TG and increased 
HDL-C. Furthermore, TG and LDL-C levels 
were lowered by natural honey in patients with 
hypertriglyceridemia and hyperlipidemia. 
Compared with dextrose and sucrose, honey 
caused lower elevation of PGL in diabetic 
patients (25). 
Almost all the previous reported effects of 
honey against cardiovascular risk factors are 
focused on lipid profiles and free radicals. 
Recently,  we  have  demonstrated  that             
short time perfusion of enriched Krebs 
solution with natural honey for 10 min before 
to 10 min after ischemia (pharmacologic 
preconditioning) had antiarrhythmic activity in 
isolated rat heart (26). However, there is no 
report regarding cardioprotective effects of 
chronic oral administration of natural honey 
against I/R injuries. Therefore, in the present 
study, effects of chronic administration of oral 
honey on I/R-induced cardiac arrhythmias 
were investigated in isolated rat heart. 
 
Materials and Methods 
Feeding animals with prepared honey 
concentrations 
Male Wistar rats weighing 270-300 g were 
used in this study. The rats were divided into 
four groups (n=10-14 in each group) and were 
fed by different concentrations of honey (1%, 
2% and 4%) for 45 days, except for the control 
group. The natural honey was purchased from 
Oskou (East Azerbaijan, Iran). To prepare the 
required concentrations of honey, different 
amounts of honey was completely dissolved in 
the drinking water of rats then the rats were 
fed with the solutions during 45 days. 
 
Animals and surgical procedure 
The  rats  were  pretreated  by  heparin            
(300 IU, i.p.) then anaesthetized with sodium 
pentobarbital (50 mg/kg, i.p.) (27). The hearts 
were  excised  rapidly  and  mounted  on  a           
non-recirculating Langendroff apparatus under    
100 mmHg pressures at 37 °C and perfused 
throughout the experiments with modified 
Krebs-Henseleit  (K/H)  solution  containing         
(in mM): NaCl (118.5), NaHCO3 (25.0), KCl 
(4.8), MgSO4 (1.2), KH2PO4 (1.2), D-glucose 
(12.0) and CaCl2 (1.7) which was gassed with 
95% O2-5% CO2. A fluid filled balloon 
introduced into the left ventricle and inflated 
to give a preload of 8–10 mmHg (27, 28). 
After 20 min stabilization, the hearts were 
subjected to 30 min regional ischemia by 
temporary occlusion of left anterior 
descending (LAD) coronary artery followed 
by 30 min reperfusion. The recorded ECGs by 
Powerlab data recorder and analyzer 
(ADInstruments, Australia), were analyzed 
based on the Lambeth conventions to 
determine the total number of ventricular 
ectopic beats (VEBs), the number of beats 
occurring as ventricular tachycardia (VT), the 
incidence and duration of VT and ventricular 
fibrillation (VF) during 30 min ischemia and 
30 min reperfusion (29, 30). 
 
Statistical analysis 
Except for the incidence of VT and VF which 
were indicated as percentage, all results were 
expressed as mean±SEM. To compare the 
number of VT, VEBs and duration of VT, VF 
between  groups,  Mann-Whitney  U  test       
(non-parametric) was employed. Analyzing 
the incidence of VT and VF was accomplished 
by Fisher Irwin test (Chi-square with Yates 
correction) (29, 31). Differences between 
groups were considered significant at a level 
of P<0.05. 
 
Results 
The effects of different concentrations of 
orally administered natural honey on I/R-
induced arrhythmias are summarized in Table 
1 and 2. 
As shown in Table 1 and Figure 1, at the 
ischemic condition (30 min), natural honey 
(1% and 2%), reduced the number of VT from 
473±166  in  the  control  group  to  26±14           
(P<0.01) and 72±54 (P<0.05), respectively. 
Duration  of  VT  was  decreased  by  the          
same concentrations (P<0.01 and P<0.05, 
respectively). Honey (1% and 2%) also led to 
a reduction in the number of VEBs (P<0.05 
and P <0.01, respectively). In addition, 
incidence and duration of reversible VF (Rev 
VF) were significantly lowered by honey 2%
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Table 1. Effects of oral honey on cardiac arrhythmias during 30 min ischemia in isolated rat hearts. 
 
Groups  VT 
number 
VEBs 
number 
VT 
duration 
(Sec) 
Rev VF 
duration 
(Sec) 
Rev VF 
incidence 
(%) 
VT 
incidence 
(%) 
Total VF     
incidence 
(%) 
Control 473±166  941±224  74±30  65±42  50 90  71 
Oral     Honey 
(1%)  26±14** 421±143* 4±2**  2±2  11  33*  11* 
Oral Honey 
(2%)  72±54* 241±116*  12±9*  0*  0*  33*  0* 
Oral Honey 
(4%)  247±101 533±109 37±11 20±15  43  71  43 
*P<0.05, **P<0.01 versus control group. VT; ventricular tachycardia, VEBs; ventricular ectopic beats 
(Single+Salvos+VT), Rev VF; reversible ventricular fibrillation. N= 10-14 rats in each group.  
 
 
Table 2. Effects of oral honey on cardiac arrhythmias during 30 min reperfusion in isolated rat hearts. 
 
 
Groups  VT number  VEBs     
number 
VT duration 
(Sec) 
Rev VF 
duration 
(Sec) 
VT 
incidence
(%) 
Rev VF  
incidence 
(%) 
Total VF     
incidence 
(%) 
 
Control 
 
140±42 
 
355±101 
 
25±7 
 
71±31 
 
73 
 
82 
 
91 
Oral                 
Honey              
(1%) 
 
7±5** 
 
257±139 
 
1±1** 
 
52±46 
 
22* 
 
33* 
 
33** 
Oral Honey 
(2%) 
 
49±32 
 
214± 87 
 
8±5 
 
82±81 
 
67 
 
33* 
 
50 
Oral Honey 
(4%) 
 
39±16 
 
101±23* 
 
6.5±3 
 
272±223 
 
71 
 
57 
 
57 
*P<0.05, **P<0.01 versus control group. VT; ventricular tachycardia, VEBs; ventricular ectopic beats 
(Single+Salvos+VT), Rev VF; reversible ventricular fibrillation. N= 10-14 rats in each group. 
 
(P<0.05). Moreover, the honey (1% and 2%) 
reduced the incidence of VT and total VF 
significantly compared to the control group 
(P<0.05). However, natural honey (4%) did 
not produce considerable changes in the 
incidence, duration and number of ischemic 
arrhythmias (Table 1).  
At the reperfusion phase as shown in Figure 
2, VT incidence was 73% in the control group, 
however natural honey (1%) decreased it to 
22% (P<0.05). In addition, total VF incidence, 
duration and number of VT showed significant 
reduction by this concentration (P<0.01). 
Administration of natural honey (1% and 2%) 
also lowered incidence of Rev VF from 82% (in 
control group) to 33% (P<0.05). Also, natural 
honey (4%) significantly reduced number of 
VEBs (P<0.05) in comparison with the control 
group (Table 2).  
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Figure 1. The total number of ventricular ectopic beats (VEBs) and ventricular tachycardia (VT) in the control and 
honey (1%, 2% and 4%) groups during 30 min ischemia. Data are represented as Mean±SEM.*P<0.05, **P<0.01 
versus control group. N=10-14 rats in each group.  
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Figure 2. The incidence (%) of ventricular tachycardia (VT), reversible ventricular fibrillation (Rev VF) and total 
ventricular fibrillation (Total VF) during 30 min reperfusion in the control group and isolated rat hearts feeding by 
different concentrations of honey (1%, 2% and 4%).*P<0.05, **P<0.01 versus control group. N= 10-14 rats in each 
group. 
 
 
Discussion 
In the present study, potential antiarrhythmic 
effects of chronic administration of natural 
honey were investigated in isolated rat heart. 
The results clearly showed that chronic oral 
administration of natural honey produced 
antiarrhythmic effects against I/R-induced 
arrhythmias. During ischemia, using natural 
honey (especially 1%) showed significant 
reduction in the number of VT, VEBs, VT 
duration and incidences of VT and total VF. 
Despite decreasing ischemic arrhythmias by 
honey (4%), the effect was not statistically 
significant compared to the control group. At 
the reperfusion phase, the lowest used 
concentration of natural honey (1%) caused 
marked antiarrhythmic effects where incidence 
of total VF, duration, incidence and number of 
VT showed significant reduction. In addition 
to 1% honey concentration administration of 
2% of honey lowered Rev VF incidence by 
49% in comparison with the control group. 
Although natural honey has been applied for 
medicinal purposes since ancient times (9), in 
the case of cardiovascular diseases, most of the 
previous studies are focused on honey's effects 
against cardiovascular risk factors such as 
hyperlipidemia and production of free radicals 
(21-25). The results of our previous work 
revealed that short time acute pre-ischemic 
administration of natural honey (0.25, 0.5 and 
1%) as a pharmacologic preconditioning agent 
had antiarrhythmic and cardioprotective 
activities in isolated rat heart (26). Despite 
some methodological differences between       
the above-mentioned studies (different 
administration period and concentration of 
honey), the results of current study are consistent 
with the previous work. That is, both acute and 
chronic administration of natural honey 
protected isolated rat heart against I/R-induced 
arrhythmias in our model of study. 
It seems that the low concentrations of oral 
honey are more effective than higher used 
concentrations. Probably, the existence of high 
amount of glucose in higher concentrations of 
honey may change glucose to lactate in 
ischemic condition then causes electrical and 
contractility disturbances in the heart (26). 
Although protective mechanism of honey is 
not clear, we suggested that similar to chronic 
administration of medications to prevent 
angina or other cardiovascular diseases, long 
time feeding of the rats with proper 
concentrations of honey for 45 days produced 
enough adaptation and prophylaxis against I/R 
injuries. The effect of honey in such condition 
is similar to ischemic preconditioning as well. 
Also we suggested that chronic effects of 
various chemical compounds in honey 
composition especially rich energy sources 
(such as glucose and fructose), vitamins, 
minerals, etc. (32, 33) have potential role to 
diminish I/R injuries. Antioxidant activity of 
honey and scavenging of free radicals 
demonstrated in some previous studies may 
play important role in the above-mentioned 
protective effects of honey as well (15-18, 34, 
35). In a study, pretreatment of anesthetized 
normal or stressed rats with natural wild honey 
(5 g/kg) for 1 hr prior to adrenaline injection 
(100 mcg/kg) could protect them from  
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epinephrine-induced vasomotor dysfunction 
and cardiac disorders and preserved the 
positive inotropic effect of adrenaline. The 
authors concluded that natural wild honey 
might cause its cardioprotective and 
therapeutic effects against adrenaline-induced 
cardiac and vasomotor dysfunction directly 
(via  its high total antioxidant capacity and 
enzymatic and nonenzymatic antioxidants, 
besides its substantial quantities of mineral 
elements such as magnesium, sodium, and 
chlorine), and/or indirectly by stimulating 
release of nitric oxide from endothelium 
through the influence of vitamin C (20). 
Little is known about the individual 
components of honey which are responsible 
for its antioxidant activity. In the study of 
Schramm  et al, oral consumption of 
buckwheat honey (1.5 g/kg), plasma total-
phenolic content and antioxidant capacities 
increased (21). Gheldof et al (2003) carried 
out a study to characterize the phenolics and 
other antioxidants present in honeys from 
seven floral sources. Chromatograms of the 
phenolic nonpolar fraction of the honeys 
indicated that most honeys have similar but 
quantitatively different phenolic profiles. 
Many of the identified flavonoids and 
phenolic acids have been previously described 
as antioxidants and may augment defenses 
against oxidative stress (15, 21). Strong 
scavenging free radicals were also shown by 
some bee products containing higher level of 
phenolic compounds (such as propolis) (36). It 
also inhibited oxidative stress which may be 
partly responsible for its neuroprotective 
activity against in vitro cell death and in vivo 
focal cerebral ischemia (36). 
In general, the antioxidant capacity of honey 
appeared to be a result of the combined 
activity of a wide range of compounds 
including phenolics, peptides, organic acids, 
enzymes, Maillard reaction products, and 
possibly other minor components (15). 
Regarding the existence of many organic 
compounds with antioxidant and radical-
scavenging activity in honey composition, it 
seems that honey has the potential capability 
to serve as an important source of natural 
antioxidants in human nutrition (35). 
 
Conclusion 
By considering the data, it may be concluded 
that chronic oral administration of honey can 
recover ischemic-reperfused isolated rat hearts 
and consequently has anti-arrhythmic activity. 
Antioxidant and radical scavenging activity, 
presence of rich energy sources, many 
vitamins, minerals and enzymes may involve 
in the cardioprotective effects of natural honey 
in isolated rat heart. Future studies are required 
to determine the exact protective mechanism 
(s) of honey.  
 
Acknowledgment 
This study was supported by the Research 
Affairs of Tabriz University of Medical 
Sciences, Tabriz, Iran. The authors declare that 
they have no conflict of interests.  
 
 
References 
1. Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. 
Circulation  2001; 104:2158–2163. 
2. Selwyn AP, Braunwald E. Ischemic heart diseases. In: Kasper LD, Fauci SA, editors. Harrison’s Principles of 
Internal Medicine. 16th ed. New York: The Mc Graw- Hill companies; 2004. p.1435- 1444. 
3. Lango R, Smolenski RT, Narkiewicz M, Suchorzewska J, Lysiak-Szydlowska W. Influence of L-carnitine and its 
derivatives on myocardial metabolism and function in ischemic heart disease and during cardiopulmonary 
bypass. Cardiovasc Res 2001; 51:21-29. 
 4. Ford  DA. Alterations in myocardial lipid metabolism during myocardial ischemia and reperfusion. Prog Lipid 
Res  2002; 41:6-26. 
5. Rizzon P, Biasco G, Di Biase M, Boscia F, Rizzo U, Minafra F, et al. High doses of L-carnitine in acute 
myocardial infarction: metabolic and anti-arrhythmic effects. Eur  Heart J 1989; 10:502-508. . 
6. Codex A limentarius Commission, author. Codex Standards for sugar (honey). Supplement 2 to codex Alimentarius, 
Volume 111. Rome: Food and Agriculture Organisation of the United Nations and World Health Organization; 1989. 
7. Moundoi MA, Padila-Zakour OI, Worobo RW. Antimicrobial activity of honey against food pathogens and food 
spoilage microorganisms. Geneva: Cornell University, NYSAES; 2001. Vol. 1 p. 61–71. 
8. Olaitan PB, Adeleke EO, Ola OI. Honey: a reservoir for microorganisms and an inhibitory agent for microbes. 
Afr Health Sci  2007; 7:159–165.  
Antiarrhythmic Effects of Oral Natural Honey 
 
 Iran J Basic Med Sci, Vol. 13, No. 4, Jan-Feb 2011   81
9. Ahmed AK, Hoekstra MJ, Hage JJ, Karim RB. Honey-medicated dressing: transformation of an ancient remedy 
into modern therapy. Ann Plast Surg  2003; 50:143-147. 
10. Ali AT, Chowdhury MN, al Humayyd MS. Inhibitory effect of natural honey on Helicobacter pylori. Trop 
Gastroenterol 1991; 12:139-143. 
11. Molan PC. The antibacterial activity of honey: The nature of the antibacterial activity. Bee World 1992; 73:5–28. 
12. Khan FR, Ul Abadin Z, Rauf N. Honey: nutritional and medicinal value. Int J Clin Pract 2007; 61:1705-1707. 
13. Asadi-Pooya A, Pnjehshahin MR, Beheshti S. The antimycobacterial effect of honey: an in vitro study. Riv Biol  
2003; 96: 491-496. 
14. Johnson DW, Eps CV, Mudge DW, Joan Wiggins K, Armstrong K, Hawley CM, et al. Randomized, controlled 
trial of topical exit-site application of honey versus mupirocin for the prevention of catheter-associated infections 
in hemodialysis patients. J Am Soc Nephrol 2005; 16: 1456–1462. 
15. Gheldof N, Wang XH, Engeseth NJ. Identification and quantification of antioxidant components of honeys 
from various floral sources. J Agric Food Chem 2002; 50:5870-5877. 
16. Baltrusˇaityt V, Venskutonis PR, Cˇ eksteryt V. Radical scavenging activity of different floral origin honey and 
beebread phenolic extracts. Food Chem 2007; 101:502–514. 
17. Gheldof N, Wang XH, Engeseth NJ. Buckwheat honey increases serum antioxidant capacity in humans. J Agric 
Food Chem 2003; 51:1500-1505.  
18. Hegazi AG, Abd El-Hady FK. Influence of honey on the suppression of human low density lipoprotein (LDL) 
peroxidation (In vitro). Evid Based Complement  Alternat Med  2009; 6:113-121.  
19. Beretta G, Orioli M, Facino RM. Antioxidant and radical scavenging activity of honey in endothelial cell 
cultures. Planta Med 2007; 73:1182-1189. 
20. Rakha MK, Nabil IZ, Hussein AA. Cardioactive and vasoactive effects of natural wild honey against cardiac 
malperformance induced by hyperadrenergic activity. J Med Food 2008; 11:91–98. 
21. Schramm DD, Karim M, Schrader HR, Holt RR, Cardetti M, Keen CL. Honey with high levels of antioxidants 
can provide protection to healthy human subjects. J Agric Food Chem  2003; 51: 1732-1735. 
22. Chepulis LM. The effect of honey compared to sucrose, mixed sugars, and a sugar-free diet on weight gain in 
young rats. J Food Sci  2007; 72: S224-S229.  
23. Bahrami M,  Ataie-Jafari A,  Hosseini S,  Forouzanfar M,  Rahmani M, Pajouhi M. Effects of natural honey 
consumption in diabetic patients: an 8-week randomized clinical trial. Int J Food Sci Nutr 2008; 2: 1-9. 
24. Yaghoobi N, Al-Waili N, Ghayour-Mobarhan M, Parizadeh SMR, Abasalti Z, Yaghoobi Z, et al. Natural honey 
and cardiovascular risk factors; effects on blood glucose,cholesterol, triacylglycerole, CRP, and body weight 
compared with sucrose. Scientific World Journal 2008; 8: 463-469. 
25. Al-Waili NS. Natural honey lowers plasma glucose, C-reactive protein, homocysteine, and blood lipids in healthy, 
diabetic, and hyperlipidemic subjects: comparison with dextrose and sucrose. J Med Food  2004; 7:100-107. 
26. Najafi M, Mahdizadeh-Aghdam E, Rafie F, Eteraf Oskouei T. Effects of pharmacologic preconditioning by 
natural honey on arrhythmias and infarct size in isolated heart, Pharm Sci J 2008; 1-11. 
27. Najafi M, Garjani A. The effect of L-carnitine on arrhythmias in the ischemic rat heart. Iran J Basic Med Sci 
2005; 8:38-44. 
28. Kristiansen SB, Nielsen–Kudsk JE, Botker HE, Nielsen TT. Effects of KATP channel modulation on myocardial 
glycogen content, lactate and amino acids in non-ischemic and ischemic rat hearts. J Cardiovasc Pharmacol  
2005; 45:456–461. 
29. Najafi M, Garjani A, Maleki N, Eteraf Oskouei T. Antiarrhythmic and arrhythmogenic effects of L-carnitine in 
ischemia and reperfusion. Bull Exp Biol Med  2008; 146:210-213. 
30. Najafi M, Nazemiyeh H, Ghavimi H, Gharakhani A, Garjani A. Effects of hydroalcoholic extract of Cynodon 
dactylon (L.) pers. on ischemia/reperfusion-induced arrhythmias. DARU 2008; 16:233-238. 
31. Najafi M, Garjani A, Eteraf Oskouei T. Comparison between the effects of ischemic preconditioning and 
pharmacologic preconditioning by L-carnitine on infarct zone size in the ischemic-reperfused isolated rat heart. 
Iran J Basic Med Sci  2007; 10:54-59. 
32. Chow J. Probiotics and prebiotics: a brief overview. J Ren Nutr  2002; 12:76-86. 
33. White JW. Composition of honey. In: Crane E, editor. Honey: A Comprehensive Survey, London: Heinemann; 
1979. p. 157–192. 
34. Bilsel Y, Bugra D, Yamaner S, Bulut T, Cevikbas U, Turkoglu U. Could honey have a place in colitis therapy? 
Effects of honey, prednisolone and disulfiram on inflammation, nitric oxide, and free radical formation. Dig Surg  
2002; 19:306-311. 
35. Zalibera M, Stasko A, Slebodova A, Jancovicova V, Cermakova T, Brezova A. Antioxidant and radical-scavenging 
activities of Slovak honeys – An electron paramagnetic resonance study. Food Chem 2008; 110:512–521. 
36. Shimazawa M, Chikamatsu S, MorimotoN, Mishima S, Nagai H, Hara H. Neuroprotection by Brazilian Green 
Propolis against in vitro and in vivo ischemic neuronal damage. Evid Based Complement Alternat Med 2005; 
2:201–207. 
 